European Commission approves TREVICTA (paliperidone palmitate 3-monthly injection), for schizophrenia


Janssen has announced that the European Commission (EC) has approved the use of TREVICTA® (paliperidone palmitate, a 3-‘monthly injection) for the maintenance treatment of schizophrenia. Source link